Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

The BeNeLuxA Medicines Access Coalition: Resetting The Balance of Power in Europe?

Executive Summary

The BeNeLuxA coalition shows that “resetting the balance of power” is possible to give governments more clout in pricing negotiations, says the European Public Health Alliance.

You may also be interested in...



Trenches, Silos And Circular Debates: European Health Forum Calls For Collaboration On IP And Medicines Access

A session on intellectual property and its effects on access to new medicines was the subject of heated debate at the recent European Health Forum Gastein conference, with proponents of strong IP protections locking horns with health activists over issues such as the link between IP and high prices.

Is Europe’s BeNeLuxA Coalition Moving Too Fast?

The BeNeLuxA initiative for improving access to medicines could soon include more countries, but much about the collaboration remains opaque for the pharmaceutical industry. Lawyer Koosje van Lessen Kloeke says constructive dialogue between the initiative and industry would benefit the collaboration.

New BeNeLuxA Access To Meds Initiative Pilots Are Under Way

Two new BeNeLuxA pilots are underway and a website detailing information about the wider initiative is likely to go live soon.

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

PS121882

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel